This study will be a randomized, double-blind, placebo controlled trial comparing pain levels in women undergoing medical abortion with one of two regimens: 1) ibuprofen 800mg and Sativex, and 2) ibuprofen 800mg and placebo at the time of misoprostol administration. Our primary objective will be to determine if a cannabinoid analgesic in addition to ibuprofen decreases maximum pain scores compared to ibuprofen and placebo when undergoing medical abortion. We plan to prospectively collect data via a text messaging system to evaluate pain scores, satisfaction, total analgesia use and adverse side effects. Results of this study will inform future providers who are counseling women undergoing medical abortion.